We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Seattle, Wash.-based ocular damage treatment company LumiThera has completed its purchase of Diopsys, a developer of retinal disorder diagnostic devices. Read More
Mountain View, Calif.-based Crosscope has teamed up with Germany’s Mindpeak to develop new digital tools designed to improve cancer diagnosis. Read More
Minnesota device developer Cardiovascular Systems (CSI) has unveiled plans to expand its reach in thrombectomy devices by partnering with California-based Innova Vascular. Read More
According to AdvaMed, the diagnostics industry has shipped approximately 800 million COVID-19 tests to laboratories across the country since March 2020, as well as more than 1 billion at-home tests. Read More
Johnson & Johnson subsidiary DePuy Synthes has acquired CrossRoads Extremity Systems, a Memphis, Tenn.-based company that will strengthen DePuy’s portfolio in elective foot and ankle implants and surgical instruments. Read More
Two Canadian companies, Imagia Cybernetics and Canexia Health, are merging to create a new entity that will focus on genomic testing and analysis for cancer patients. Read More
Cambridge, Mass.-based Foundation Medicine has teamed up with Eli Lilly for the development of tissue- and blood-based assays as companion diagnostics for Lilly’s cancer drug Retevmo and other therapies. Read More
The litigation included patent infringement claims in the U.S. District Courts for the District of Delaware and the Eastern District of Texas. Read More